Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2279-2285

  Korita, Pavel V ^a   Wakai, Toshifumi ^a   Ajioka, Yoichi ^a   Inoue, Makoto ^a   Takamura, Masaaki ^a   Shirai, Yoshio ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Intrahepatic cholangiocarcinoma; Prognosis; Surgical resection; Vimentin

Indexed keywords

VIMENTIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER RESECTION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR DIFFERENTIATION;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL DIFFERENTIATION; CHOLANGIOCARCINOMA; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MESODERM; MIDDLE AGED; PROGNOSIS; VIMENTIN;

EID: 77955084824     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Steinert PM and Roop DR: Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 57: 593-625, 1988.
2. Oshima RG: Intermediate filaments: a historical perspective. Exp Cell Res 313: 1981-1994, 2007.
3. Herrmann H, Bär H, Kreplak L, Strelkov SV and Aebi U: Intermediate filaments: from cell architecture to nanomechanics. Nat Rev Mol Cell Biol 8: 562-573, 2007. (Pubitemid 46985377)
4. Maniotis AJ, Chen CS and Ingber DE: Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci USA 94: 849-854, 1997.
5. Ivaska J, Pallari HM, Nevo J and Eriksson JE: Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 313: 2050-2062, 2007.
6. Hendrix MJ, Seftor EA, Seftor RE and Trevor KT: Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 150: 483-495, 1997.
7. McInroy L and Määttä A: Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 360: 109-114, 2007. (Pubitemid 46990330)
8. Zhao Y, Yan Q, Long X, Chen X and Wang Y: Vimentin affects the mobility and invasiveness of prostate cancer cells. Cell Biochem Funct 26: 571-577, 2008.
9. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
10. Thompson EW, Newgreen DF and Tarin D: Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995, 2005.
11. Al-Saad S, Al-Shibli K, Donnem T, Persson M, Bremnes RM and Busund LT: The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small cell lung cancer. Br J Cancer 99: 1476-1483, 2008.
12. Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S and Figlin RA: Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 173: 1496-1501, 2005.
13. Nakajima T, Tajima Y, Sugano I, Nagao K, Kondo Y and Wada K: Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases. Cancer 72: 1872-1877, 1993.
14. Shimada M, Takenaka K, Rikimaru T, Hamatsu T, Yamashita Y, Kajiyama K, Taguchi K, Shirabe K and Sugimachi K: Characteristics of sarcomatous cholangiocarcinoma of the liver. Hepatogastroenterology 47: 956-961, 2000.
15. Matsuo S, Shinozaki T, Yamaguchi S, Takami Y, Obata S, Tsuda N and Kanematsu T: Intrahepatic cholangiocarcinoma with extensive sarcomatous change: report of a case. Surg Today 29: 560-563, 1999.
16. Kaibori M, Kawaguchi Y, Yokoigawa N, Yanagida H, Takai S, Kwon AH, Uemura Y and Kamiyama Y: Intrahepatic sarcomatoid cholangiocarcinoma. J Gastroenterol 38: 1097-1101, 2003.
17. Lim BJ, Kim KS, Lim JS, Kim MJ, Park C and Park YN: Rhabdoid cholangiocarcinoma: a variant of cholangiocarcinoma with aggressive behavior. Yonsei Med J 45: 543-546, 2004. (Pubitemid 39010716)
18. Tsou YK, Wu RC, Hung CF and Lee CS: Intrahepatic sarcomatoid cholangiocarcinoma: clinical analysis of seven cases during a 15-year period. Chang Gung Med J 31: 599-605, 2008.
19. Strasberg SM: The Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB 2: 333-339, 2000.
20. Sobin LH, Gospodarowicz MK and Wittekind Ch (eds.): UICC. TNM Classification of Malignant Tumours, 7th edition. New York: John Wiley and Sons, Inc., 2009.
21. Nakanuma Y and Kono N: Expression of vimentin in proliferating and damaged bile ductules and interlobular bile ducts in nonneoplastic hepatobiliary diseases. Mod Pathol 5: 550-554, 1992.
22. Kozaka K, Sasaki M, Fujii T, Harada K, Zen Y, Sato Y, Sawada S, Minato H, Matsui O and Nakanuma Y: A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: bile ductular carcinoma. Histopathology 51: 390-400, 2007.
23. Sobin LH and Wittekind Ch (eds.): UICC. TNM Classification of Malignant Tumours, 6th edition. New York: John Wiley and Sons, Inc., 2002.
24. van der Velden LA, Schaafsma HE, Manni JJ, Ruiter DJ, Ramaekers FC and Kuijpers W: Cytokeratin and vimentin expression in normal epithelium and squamous cell carcinomas of the larynx. Eur Arch Otorhinolaryngol 254: 376-383, 1997.
25. Thomas PA, Kirschmann DA, Cerhan JR, Folberg R, Seftor EA, Sellers TA and Hendrix MJ: Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res 5: 2698-2703, 1999. (Pubitemid 29493942)
26. Korsching E, Packeisen J, Liedtke C, Hungermann D, Wülfing P, van Diest PJ, Brandt B, Boecker W and Buerger H: The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206: 451-457, 2005.
27. Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA and Summerhayes IC: Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 13: 1685-1694, 2007.
28. Sasaki M, Nakanuma Y, Nagai Y and Nonomura A: Intrahepatic cholangiocarcinoma with sarcomatous transformation: an autopsy case. J Clin Gastroenterol 13: 220-225, 1991.
29. Imazu H, Ochiai M and Funabiki T: Intrahepatic sarcomatous cholangiocarcinoma. J Gastroenterol 30: 677-682, 1995.
30. Honda M, Enjoji M, Sakai H, Yamamoto I, Tsuneyoshi M and Nawata H: Case report: intrahepatic cholangiocarcinoma with rhabdoid transformation. J Gastroenterol Hepatol 11: 771-774, 1996.
31. Sato K, Murai H, Ueda Y and Katsuda S: Intrahepatic sarcomatoid cholangiocarcinoma of round cell variant: a case report and immunohistochemical studies. Virchows Arch 449: 585-590, 2006.
32. Sumiyoshi S, Kikuyama M, Matsubayashi Y, Kageyama F, Ide Y, Kobayashi Y and Nakamura H: Carcinosarcoma of the liver with mesenchymal differentiation. World J Gastroenterol 13: 809-812, 2007.
33. Vongwiwatana A, Tasanarong A, Rayner DC, Melk A and Halloran PF: Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant 5: 1367-1374, 2005. (Pubitemid 40839427)
34. Yang J and Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829,2008. (Pubitemid 351757205)